Advanced

BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas

Nyman, H; Jerkeman, Mats LU ; Karjalainen-Lindsberg, M; Banham, A; Enblad, G and Leppa, S (2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.142-142
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Annals of Oncology
volume
19
issue
Suppl. 4
pages
142 - 142
publisher
Oxford University Press
conference name
10th International Conference on Malignant Lymphoma
external identifiers
  • wos:000256693500204
ISSN
1569-8041
DOI
10.1093/annonc/mdn237
language
English
LU publication?
yes
id
2f3bf4ae-e071-4762-8f65-dcadb99cb6a7 (old id 1200507)
date added to LUP
2008-09-12 14:02:17
date last changed
2016-08-22 09:57:42
@misc{2f3bf4ae-e071-4762-8f65-dcadb99cb6a7,
  author       = {Nyman, H and Jerkeman, Mats and Karjalainen-Lindsberg, M and Banham, A and Enblad, G and Leppa, S},
  issn         = {1569-8041},
  language     = {eng},
  note         = {Conference Abstract},
  number       = {Suppl. 4},
  pages        = {142--142},
  publisher    = {Oxford University Press},
  series       = {Annals of Oncology},
  title        = {BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas},
  url          = {http://dx.doi.org/10.1093/annonc/mdn237},
  volume       = {19},
  year         = {2008},
}